Federal Circuit Affirms Validity of Pfizer's Lyrica (Pregabalin) Patent
Pfizer Inc. et al. v. Teva Pharms. USA et al., No. 2012-1576 (Fed. Cir.) Teva and several other generic pharmaceutical companies each submitted an
Pfizer Inc. et al. v. Teva Pharms. USA et al., No. 2012-1576 (Fed. Cir.) Teva and several other generic pharmaceutical companies each submitted an
Amneal Pharmaceuticals, LLC v. Supernus Pharmaceuticals, Inc., IPR2013-00368, IPR2013-00371, IPR2013-00372 (PTAB) by Robert F. Kappers The
Galderma Labs., L.P. et al. v. Tolmar, Inc., No. 2013-1034 (Fed. Cir.) by Dunstan H. Barnes On December 11, 2013, a three-judge Federal Circuit
Cadence Pharms., Inc. v. Exela Scis., LLC, No. 11-733-LPS (D. Del.) by Dunstan H. Barnes On November 22, 2013, the U.S. District Court for the
Accord Healthcare v. Eli Lilly and Co., IPR2013-00356 (PTAB) by Herbert D. Hart III On October 1, 2013, the Patent Trial and Appeal Board
Novo Nordisk v. Caraco Pharm. Labs., No. 2011-1223 (Fed. Cir.) by Timothy M. Long In its third trip to the Federal Circuit, the court on